Patrick Dorn

1.6k total citations
75 papers, 952 citations indexed

About

Patrick Dorn is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Patrick Dorn has authored 75 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 22 papers in Molecular Biology and 21 papers in Oncology. Recurrent topics in Patrick Dorn's work include Occupational and environmental lung diseases (12 papers), Pleural and Pulmonary Diseases (12 papers) and Lung Cancer Diagnosis and Treatment (10 papers). Patrick Dorn is often cited by papers focused on Occupational and environmental lung diseases (12 papers), Pleural and Pulmonary Diseases (12 papers) and Lung Cancer Diagnosis and Treatment (10 papers). Patrick Dorn collaborates with scholars based in Switzerland, China and Germany. Patrick Dorn's co-authors include Ralph A. Schmid, Ren‐Wang Peng, Thomas M. Marti, Gregor J. Kocher, Sabina Berezowska, Laurène Froment, Giuseppe Cardillo, Nick Maskell, José M. Porcel and J. Janssen and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Patrick Dorn

62 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Dorn Switzerland 16 510 267 228 169 121 75 952
Kenneth N. Vanek United States 13 159 0.3× 133 0.5× 116 0.5× 155 0.9× 115 1.0× 25 741
Lama Sakr Canada 13 471 0.9× 110 0.4× 212 0.9× 142 0.8× 78 0.6× 30 789
Liyun Cao United States 14 293 0.6× 350 1.3× 279 1.2× 70 0.4× 133 1.1× 25 945
L Heikkilä Finland 14 343 0.7× 193 0.7× 137 0.6× 312 1.8× 125 1.0× 47 864
Jiacheng Yin China 13 393 0.8× 234 0.9× 289 1.3× 130 0.8× 155 1.3× 25 753
Yifeng Sun China 16 223 0.4× 254 1.0× 102 0.4× 182 1.1× 103 0.9× 58 701
D. Nagel Germany 11 261 0.5× 228 0.9× 405 1.8× 279 1.7× 276 2.3× 24 960
Deepak Hariharan United Kingdom 11 190 0.4× 221 0.8× 381 1.7× 410 2.4× 119 1.0× 21 869

Countries citing papers authored by Patrick Dorn

Since Specialization
Citations

This map shows the geographic impact of Patrick Dorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Dorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Dorn more than expected).

Fields of papers citing papers by Patrick Dorn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Dorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Dorn. The network helps show where Patrick Dorn may publish in the future.

Co-authorship network of co-authors of Patrick Dorn

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Dorn. A scholar is included among the top collaborators of Patrick Dorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Dorn. Patrick Dorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Duo, Yanyun Gao, Tong Hu, et al.. (2025). De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma. EMBO Molecular Medicine. 17(9). 2258–2298.
2.
Şenbaklavacı, Ömer, et al.. (2025). Risk factors for prolonged air leak after uniportal anatomical segmentectomy. European Journal of Cardio-Thoracic Surgery. 67(3). 1 indexed citations
3.
Lin, Ya‐Wen, Christelle Dubey, Jean‐Louis Reymond, et al.. (2025). Inhibition of LDHB triggers DNA damage and increases cisplatin sensitivity in pleural mesothelioma. Oncogenesis. 14(1). 28–28.
4.
Yang, Haitang, Sean R. R. Hall, Gang Liu, et al.. (2025). Transitional CXCL14+ cancer‐associated fibroblasts enhance tumour metastasis and confer resistance to EGFR‐TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinoma. Clinical and Translational Medicine. 15(4). e70281–e70281. 5 indexed citations
5.
Zhao, Liang, Jingyi Zhang, Nicola Zamboni, et al.. (2024). Lactate dehydrogenase B noncanonically promotes ferroptosis defense in KRAS-driven lung cancer. Cell Death and Differentiation. 32(4). 632–645. 10 indexed citations
6.
Gao, Yanyun, Fabian Blank, Michaela Medová, et al.. (2024). Inhibition of LDHB suppresses the metastatic potential of lung cancer by reducing mitochondrial GSH catabolism. Cancer Letters. 611. 217353–217353. 4 indexed citations
7.
Dorn, Patrick, et al.. (2024). Pulmonary Sequestration: A Monocentric Case Series Report. Journal of Clinical Medicine. 13(19). 5784–5784.
8.
Xu, Duo, Yanyun Gao, Haitang Yang, et al.. (2024). BAP1 Deficiency Inflames the Tumor Immune Microenvironment and Is a Candidate Biomarker for Immunotherapy Response in Malignant Pleural Mesothelioma. JTO Clinical and Research Reports. 5(5). 100672–100672. 5 indexed citations
9.
Yang, Haitang, Yanyun Gao, Duo Xu, et al.. (2023). MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma. Cell Death Discovery. 9(1). 55–55. 8 indexed citations
10.
Dorn, Patrick, et al.. (2023). Clinical and Oncological Outcomes after Uniportal Anatomical Segmentectomy for Stage IA Non-Small Cell Lung Cancer. Medicina. 59(6). 1064–1064. 1 indexed citations
11.
Kocher, Gregor J., et al.. (2023). Randomized Controlled Trial of Thresholds for Drain Removal After Anatomic Lung Resection. The Annals of Thoracic Surgery. 117(6). 1103–1109. 1 indexed citations
12.
Gao, Yanyun, et al.. (2022). Schedule-Dependent Treatment Increases Chemotherapy Efficacy in Malignant Pleural Mesothelioma. International Journal of Molecular Sciences. 23(19). 11949–11949. 5 indexed citations
13.
Xu, Duo, Xi Wu, Thomas M. Marti, et al.. (2022). Dissecting the Immunological Profiles in NSD3-Amplified LUSC through Integrative Multi-Scale Analyses. Cancers. 14(20). 4997–4997. 7 indexed citations
14.
Dorn, Patrick, Fabrizio Minervini, Peter Kestenholz, et al.. (2021). Robotic-Assisted Thoracoscopic Resection of the First Rib for Vascular Thoracic Outlet Syndrome: The New Gold Standard of Treatment?. Journal of Clinical Medicine. 10(17). 3952–3952. 8 indexed citations
15.
Xu, Duo, Haitang Yang, Yang Zhang, et al.. (2019). Endoplasmic Reticulum Stress Signaling as a Therapeutic Target in Malignant Pleural Mesothelioma. Cancers. 11(10). 1502–1502. 29 indexed citations
16.
Gao, Yanyun, Patrick Dorn, Sean R. R. Hall, et al.. (2019). Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment. Cancer Cell International. 19(1). 317–317. 30 indexed citations
17.
Gao, Yanyun, Nina Hobi, Sabina Berezowska, et al.. (2018). Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549. Neoplasia. 21(2). 185–196. 46 indexed citations
18.
Baumgartner, Ulrich, Stefan Haemmig, Stephan Schäfer, et al.. (2016). miR-29b Mediates NF-κB Signaling in KRAS-Induced Non–Small Cell Lung Cancers. Cancer Research. 76(14). 4160–4169. 48 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth N. Vanek Breakdown of academic impact, for papers by Lama Sakr Breakdown of academic impact, for papers by Liyun Cao Breakdown of academic impact, for papers by L Heikkilä Breakdown of academic impact, for papers by Jiacheng Yin Breakdown of academic impact, for papers by Yifeng Sun Breakdown of academic impact, for papers by D. Nagel Breakdown of academic impact, for papers by Deepak Hariharan
Rankless by CCL
2026